Fibrogen Inc
FGEN
Revenue
50.64M
▼-5.26M▼-9.41%
3 Months ChangeAssets
293.20M
▼-72.67M▼-19.86%
3 Months ChangeLiabilities
483.58M
▼-68.45M▼-12.40%
3 Months ChangeFree Cash Flow
-59.32M
▲42.87M▲41.95%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0000950170-24-112331
2024-09-16
Form 8-K
ID: 0000950170-24-106818
2024-09-13
Form 8-K
ID: 0000950170-24-106359
2024-09-06
Form 8-K
ID: 0000950170-24-104395
2024-08-07
Form 8-K
ID: 0000950170-24-092967
2024-08-06
Form 10-Q
ID: 0000950170-24-091808
2024-08-06
Form 8-K
ID: 0000950170-24-091766
2024-06-26
Form 8-K
ID: 0000950170-24-077616
2024-06-07
Form 8-K
ID: 0000950170-24-070636
2024-05-06
Form 10-Q
ID: 0000950170-24-053554